T-group (topology)
101.1.2 winged helix domain
Ligands and drugs
39,290
Member domains
2,913
with ligand contacts (≤ 4 Å)
7.4% of members
2,271
with DrugDomain annotations
5.8% of members
1,117
with a DrugBank compound
2.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 101.1.2 belongs to X-group 101 HTH, which binds 8.7 ligand superclasses per 20 proteins, broader than 73% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02527 | CMP | Cyclic adenosine monophosphate | 39 |
| DB00218 | MFX | Moxifloxacin | 17 |
| DB00936 | SAL | Salicylic acid | 17 |
| DB00143 | GSH | Glutathione | 16 |
| DB00773 | EVP | Etoposide | 16 |
| DB00130 | GLN | L-Glutamine | 15 |
| DB01137 | LFX | Levofloxacin | 15 |
| DB16833 | ADP | Adenosine disphosphate | 15 |
| DB01643 | TMP | Thymidine monophosphate | 14 |
| DB03345 | BME | Mercaptoethanol | 13 |
| DB00694 | DM1 | Daunorubicin | 10 |
| DB12134 | JHN | Gepotidacin | 10 |
| DB18267 | HEM | Ferroheme | 8 |
| DB00685 | TR6 | Trovafloxacin | 7 |
| DB14128 | NAD | Nadide | 7 |
| DB03843 | FOR | Formaldehyde | 6 |
| DB04066 | HC4 | p-Coumaric acid | 6 |
| DB15345 | 6EJ | GSK-945237 | 6 |
| DB00134 | MET | Methionine | 5 |
| DB00145 | GLY | Glycine | 5 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 486 |
| CL | CHLORIDE ION | 246 |
| ZNmetal | ZINC ION | 226 |
| NAmetal | SODIUM ION | 143 |
| MNmetal | MANGANESE (II) ION | 85 |
| Kmetal | POTASSIUM ION | 64 |
| CAmetal | CALCIUM ION | 59 |
| CMP | ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE | 42 |
| COmetal | COBALT (II) ION | 41 |
| NImetal | NICKEL (II) ION | 40 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 35 |
| OHX | osmium (III) hexammine | 33 |
| SF4 | IRON/SULFUR CLUSTER | 31 |
| C2E | 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one) | 30 |
| BR | BROMIDE ION | 26 |
| EVP | (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside | 25 |
| CDmetal | CADMIUM ION | 24 |
| FES | FE2/S2 (INORGANIC) CLUSTER | 22 |
| SAL | 2-HYDROXYBENZOIC ACID | 21 |
| UNX | UNKNOWN ATOM OR ION | 20 |